Andrew Allen

Andrew Allen

Company: Gritstone bio

Job title: CEO

Seminars:

Considerations for the Development of Personalised Neoantigen-Based Cancer Vaccines 9:00 am

• Reviewing updates on current individualised cancer vaccine clinical approaches, successes, and challenges • Considering factors for process design and specifications for a personalised neoantigen-based vaccine and a customised neoantigen based cell therapy • Exploring approaches for dealing with human and process variabilityRead more

day: Day One

Industry Leader’s Fireside Chat 10:40 am

• Highlighting the greatest challenges in cancer vaccine development and where the opportunity lies • Considering the competitive vaccine manufacturing landscape and how the neoantigen community will compete • Meeting investor expectations for timelines and budgets while performing true discovery scienceRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.